<DOC>
	<DOCNO>NCT02513875</DOCNO>
	<brief_summary>The work plan follow S &amp; T component . Component 1 : Cross-sectional Study Cross-sectional study 1.5 year 400 woman rural screen randomly vitamin D deficiency determinant include duration sun exposure . Component 2 : Prospective Study This open-label randomized placebo-controlled trial would do 150 pre-diabetic woman vitamin D deficiency . The woman recruit cross-sectional study , patient department health camp follow 2 year . The woman randomize two group ; lifestyle modification counsel along intervention either vitamin D placebo . The level vitamin D blood glucose assess periodically ( every 6 month ) . In recurrent vitamin D deficiency , course vitamin D repeat . At end study , incidence T2DM group compare .</brief_summary>
	<brief_title>Prevention Type 2 Diabetes With Vitamin D</brief_title>
	<detailed_description />
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Healthy woman age 2060 year . Received Vitamin D calcium supplementation previous six month . On medication within last one month could potentially influence insulin secretion , insulin sensitivity , vitamin D calcium metabolism ( e.g . metformin , thiazolidenediones , steroid etc . ) medication activate steroid xenobiotic receptor , drug use transplantation Pregnancy lactation time study Severe end organ damage chronic disease : renal/hepatic failure , malignancy , major systemic illness etc . Known case HIV infection . Known case diabetes mellitus endocrine disorder .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>